Pilot Study

This study demonstrated the ability of the breast cancer test to distinguish between cancerous and non-cancerous breast samples. The published data showed that PreMD’s test demonstrated a statistically significant difference between early-stage breast cancer and non-cancerous samples (Paired T-Test = 0.001), which demonstrates the test's effectiveness in identifying early-stage disease.

View Abstract - Prospective Evaluation of GOS Reaction in Nipple Aspirate Fluid                      from Women with Invasive Breast Cancer